CLSA Board of Directors
Global Head, Johnson & Johnson Innovation, JLABS
Executive Vice President, Corporate Affairs and Chief Communications Officer, Allergan
President and CEO, Ambys Medicines
Bruce W. Jenett
Senior Counsel, DLA Piper LLP (US)
Partner, Covington & Burling LLP
Chief Executive Officer OncoCyte
Senior Vice President, Managed Markets, Takeda Pharmaceuticals USA
Worldwide President, Medication Management Solutions, Becton, Dickinson And Company (BD)
David Beier, J.D.
Managing Director, Bay City Capital
Senior Vice President, Government Affairs, Genentech
Victoria H. Blatter
Senior Vice President, U.S. Government Affairs, Amgen
National Vice President, State Government Relations, Pfizer
Ho Sung Cho
Vice President, Biotherapeutics, Celgene
David H. Crean
Managing Director & Partner, Objective Capital Partners
Principal, Healthcare and Life Sciences, KPMG
Chief Financial Officer, Gossamer Bio
Elizabeth Grammer, Esq.
Executive Vice President, General Counsel and Head of Human Resources, Ardelyx, Inc.
Jennifer A. Johnson, Ph.D.
Associate General Counsel, DuPont Nutrition & Biosciences
Steve A. Kay, Ph.D., D.Sc.
Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California
Larry Kwak, M.D., Ph.D.
Vice President and Cancer Center Associate Director
Director, Toni Stephenson Lymphoma Center
Corporate Vice President, Public Affairs, Edwards Lifesciences
CEO, Co-founder, and Chairman, Cortexyme
Principal, Life Science Practice, Deloitte
President and Chief Executive Officer, CytomX
Grace Han McMahon
Head of Transactions, Pacific Innovation Hub, Business Development & Licensing, Merck Research Laboratories
Shlomo Melmed, MB, ChB, MACP
Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System
Director, President and Chief Executive Officer, Amyris
Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP
Senior Vice President, Managed Markets and Government Affairs, GlaxoSmithKline
Founder, CEO, and Chairman, Viscient Biosciences
William J. Newell
Chief Executive Officer, Sutro Biopharma, Inc.
President and Chief Executive Officer, Codexis
Christian W. Nolet
Joshua J. Ofman, M.D., M.S.H.S
Chief of Corporate Strategy and External Affairs, Grail
Matthew Plunkett, Ph.D.
Senior Vice President & Chief Financial Officer, Nkarta Therapeutics
Vice President and General Manager, Neurovascular, Medtronic
Ganesh Raman, Ph.D.
Associate Vice Chancellor for Research, California State University
Co-Chief Executive Officer, Alexandria Real Estate (ARE)
Wendye Robbins, MD
President & CEO, Blade Therapeutics
Partner, Hogan Lovells US LLP
Daria Mochly-Rosen, Ph.D.
The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology, Stanford University School of Medicine
Terry Rosen, Ph.D.
Chief Executive Officer, Arcus Biosciences
George Savage M.D.
Co-Founder, Chief Medical Officer, Proteus Digital Health
Partner, Assurance Services – Life Sciences Practice, Ernst & Young
Chief Creative Officer, W20 Group
Lesley Stolz, Ph.D.
Managing Director, Lasana Partners
Mohit Trikha, Ph.D.
Vice President, Head of Oncology Early Development, AbbVie
Harold E. Van Wart, Ph.D.
Vice-President, Government Affairs and Public Policy, Boehringer Ingelheim
Senior Vice President, Diabetes Care, Abbott
Rick E Winningham
Chairman and CEO, Theravance Biopharma